Drug Shortage Report for MYLAN-ESOMEPRAZOLE
Report ID | 33989 |
Drug Identification Number | 02383047 |
Brand name | MYLAN-ESOMEPRAZOLE |
Common or Proper name | ESOMEPRAZOLE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ESOMEPRAZOLE |
Strength(s) | 40MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 BT |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-02-12 |
Actual start date | 2018-01-12 |
Estimated end date | 2018-03-02 |
Actual end date | 2018-02-28 |
Shortage status | Resolved |
Updated date | 2018-03-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-12-20 | French | Compare |
v1 | 2017-12-20 | English | Compare |